Stock BRAINSTORM CELL THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Brainstorm Cell Therapeutics Inc OTC Bulletin Board

Equities

US10501E1029

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Brainstorm Cell Therapeutics Inc
Apr. 17 Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 CI
Apr. 17 Brainstorm Cell Therapeutics Inc. Announces Management Changes CI

Chart calendar Brainstorm Cell Therapeutics Inc

ab157d.RbBBnT-U9GITT_sperNWYHbNCEfAsgtlsDR-SZ6LjH4.DsQ7zVnkhykgCK1fD9YQBSz1WCGvxE9T-GYWOMrj5Tgj1XLEdO3ZAFoOsg~82873aaa1a52727908767f0e8d5fca59

Upcoming events on Brainstorm Cell Therapeutics Inc

2024-05-09 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Brainstorm Cell Therapeutics Inc

2024-04-09 08:00 am Business Update Call
2024-04-01 08:05 am Q4 2023 Earnings Release
2024-03-05 European Life Sciences CEO Forum
2024-03-04 06:00 pm MDA Clinical and Scientific Conference
2024-02-28 11:20 am European Life Sciences CEO Forum
2024-02-28 07:40 am European Life Sciences CEO Forum
2023-12-17 Annual General Meeting
2023-11-14 08:30 am Q3 2023 Earnings Call
2023-11-14 07:05 am Q3 2023 Earnings Release
2023-10-18 08:30 am Business Update Call
2023-09-26 ADCOM Conference
2023-08-14 08:00 am Q2 2023 Earnings Call
2023-08-14 07:05 am Q2 2023 Earnings Release
2023-07-05 12:00 pm Gordon Research Conference
2023-06-21 09:00 am Maxim Group Virtual Healthcare Conference
2023-05-15 08:00 am Q1 2023 Earnings Call
2023-05-15 07:05 am Q1 2023 Earnings Release
2023-03-30 08:00 am Q4 2022 Earnings Call
2023-03-30 07:05 am Q4 2022 Earnings Release
2023-03-27 08:00 am Business Update Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-23,0
-20,4
-13%		-31,7
-26,3
-20.41%		-24,5
-29,0
15.32%		-24,8
-25,9
4.18%		-21,4
-25,3
15.2%
-21,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-23,3
-20,5
-13.33%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-25,2
31.71%
-21,9

Net income
Million USD		Released
Forecast
Spread 		-23,3
-20,2
-15.39%		-31,8
-26,1
-21.82%		-24,5
-28,7
14.93%		-24,3
-25,5
4.66%		-17,2
-23,0
25.37%
-21,9

EPS
USD		Released
Forecast
Spread 		-1,06
-0,91
-17.13%		-1,07
-0,89
-20.22%		-0,68
-0,79
13.92%		-0,66
-0,68
2.22%		-0,40
-0,56
28.57%
-0,28

Announcement Date18/02/2004/02/2128/03/2230/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,21
-7,17
13.3%		-5,48
-4,70
-16.49%		-7,59
-5,46
-39.14%		-6,84
-6,75
-1.39%		-4,92
-6,00
18.08%		-5,15
-6,01
14.24%		-5,45
-5,70
4.43%		-6,04
-6,00
-0.56%		-4,80
-6,33
24.1%
-4,50


-5,20


-5,80


-6,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

Net income
Million USD		Released
Forecast
Spread 		-6,19
-7,17
13.61%		-5,36
-4,70
-14.04%		-7,04
-5,46
-29.06%		-6,86
-6,75
-1.65%		-5,02
-6,00
16.37%		-5,06
-5,96
15.06%		-5,33
-5,65
5.71%		-1,23
-6,00
79.57%		-5,58
-6,33
11.87%
-4,50


-5,20


-5,80


-6,40

EPS
USD		Released
Forecast
Spread 		-0,17
-0,20
12.82%		-0,15
-0,13
-15.38%		-0,19
-0,15
-31.03%		-0,19
-0,18
-5.56%		-0,13
-0,15
10.34%		-0,14
-0,17
15.15%		-0,13
-0,15
10.34%		-0,03
-0,15
79.31%		-0,11
-0,13
15.38%
-0,07


-0,07


-0,06


-0,07

Announcement Date28/03/2216/05/2215/08/2214/11/2230/03/2315/05/2314/08/2314/11/2301/04/24----

Upcoming sector events for Brainstorm Cell Therapeutics Inc

2024-04-25 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
2024-04-25 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-26 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
More events

Past sector events for Brainstorm Cell Therapeutics Inc

Today PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release
Today HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release
Today PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-24 04:15 pm ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release
2024-04-24 10:21 am SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release
2024-04-24 07:06 am CUREVAC N.V.: Q4 2023 Earnings Release
2024-04-24 01:45 am ADDLIFE AB: Q1 2024 Earnings Release
2024-04-24 01:00 am EVOTEC SE: Q4 2023 Earnings Release
2024-04-23 SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release
2024-04-23 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. Stock
  5. Calendar Brainstorm Cell Therapeutics Inc